Literature DB >> 2401566

Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice.

C A Salkowski1, E Balish.   

Abstract

Mortality after intravenous challenge with 10(4) Cryptococcus neoformans demonstrated that doubly immunodeficient beige athymic (bg/bg nu/nu) mice were more susceptible to systemic cryptococcosis than either bg/bg or nu/nu mice. Infected bg/bg nu/nu mice also had a shortened lifespan compared with their bg/bg nu/+ littermates. Beige athymic (bg/bg nu/nu) but not bg/bg nu/+mice developed cryptococcal lesions in the skin, demonstrating that C. neoformans is dermatotropic in a T-cell-deficient host. Higher numbers of C. neoformans were isolated from the lungs and spleen of infected bg/bg nu/nu than bg/bg nu/+ mice as early as day 3 after challenge, indicating that in lymphoid-rich organs, T cells can alter the course of systemic cryptococcosis early in the infection. Despite extensive abscess formation in the brains of bg/bg nu/+ mice, dissemination and growth rate of C. neoformans in the brain was similar in both genotypes. The primary histopathological feature in tissues from bg/bg nu/nu mice infected with C. neoformans consisted of foci of encapsulated yeast cells with minimal to no inflammatory response. In contrast to bg/bg nu/nu mice, bg/bg nu/+ mice mounted a vigorous inflammatory response to C. neoformans that progressed from acute to chronic inflammation. Beige athymic mice are a new animal model that will be useful in clarifying the innate and acquired immune factors important in resistance to cryptococcosis.

Entities:  

Mesh:

Year:  1990        PMID: 2401566      PMCID: PMC313653          DOI: 10.1128/iai.58.10.3300-3306.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.

Authors:  J W Murphy; R A Cox
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

2.  Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome.

Authors:  G V Quinnan; A H Rook; W R Frederick; J F Manischewitz; J S Epstein; J Siegel; H Masur; A M Macher; C Mitchell; G Armstrong
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

3.  Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.

Authors:  M F Miller; T G Mitchell; W J Storkus; J R Dawson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 4.  Pathology of the mycoses in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  F W Chandler
Journal:  Curr Top Med Mycol       Date:  1985

5.  Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with AIDS.

Authors:  M J Rico; N S Penneys
Journal:  Arch Dermatol       Date:  1985-07

6.  Natural cellular resistance of beige mice against Cryptococcus neoformans.

Authors:  M R Hidore; J W Murphy
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

7.  Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.

Authors:  S M Levitz; D J DiBenedetto
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.

Authors:  D L Granger; J R Perfect; D T Durack
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Influence of cryptococcal antigens on cell-mediated immunity.

Authors:  J W Murphy
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

10.  Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.

Authors:  C H Mody; M F Lipscomb; N E Street; G B Toews
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

View more
  8 in total

1.  Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.

Authors:  L Liu; K Wakamatsu; S Ito; P R Williamson
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.

Authors:  E Blasi; R Barluzzi; R Mazzolla; F Bistoni
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).

Authors:  C Lacroix; F Chau; C Carbon; M Sinet; F Derouin
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

6.  Cutaneous cryptococcosis in athymic and beige-athymic mice.

Authors:  C A Salkowski; E Balish
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization.

Authors:  E Blasi; R Barluzzi; R Mazzolla; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  Risk factors for invasive Cryptococcus neoformans diseases: a case-control study.

Authors:  Ying-Ying Lin; Stephanie Shiau; Chi-Tai Fang
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.